Malignant glioma modulation of immune function: relative contribution of different soluble factors
- 31 August 1991
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 33 (2) , 89-96
- https://doi.org/10.1016/0165-5728(91)90052-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Inhibition of growth of established human glioma cell lines by modulators of the protein kinase-C systemJournal of Neurosurgery, 1990
- Influence of PGE2- and cAMP-modulating agents on human glioblastoma cell killing by interleukin-2-activated lymphocytesJournal of Neurosurgery, 1990
- Characterization of lymphoid cells isolated from human gliomasJournal of Neurosurgery, 1989
- Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor β2Journal of Neurosurgery, 1989
- In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancersJournal of Neurosurgery, 1988
- Inhibition of lymphocyte responsiveness by a glial tumor cell-derived suppressive factorJournal of Neurosurgery, 1987
- Production of prostaglandins and thromboxane by isolated cells from intracranial tumours.Journal of Neurology, Neurosurgery & Psychiatry, 1984
- Synthesis of a PDGF-like growth factor in human glioma and sarcoma cells suggests the expression of the cellular homologue to the transforming protein of simian sarcoma virusBiochemical and Biophysical Research Communications, 1983
- Immunoregulatory Cell Function in Peripheral Blood Leukocytes of Patients with Intracranial GliomasNeurosurgery, 1982
- Immunobiology of primary intracranial tumorsJournal of Neurosurgery, 1977